Artelo Biosciences Inc. (ARTL)
NasdaqCM: ARTL
· 실시간 가격 · USD
0.72
-0.07 (-8.86%)
종가 기준: Aug 17, 2026, 3:59 PM
0.71
-1.17%
애프터마켓: 7:26 PM
Artelo Biosciences Inc. (ARTL) Stock Price, Analysis & Data
-8.86% (1D)
ARTL 소개
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpy...
전체 기업 정보재무 실적
2025년 Artelo Biosciences의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -12.88M로, 31.07% 증가했습니다.
재무제표어닝 서프라이즈
Artelo Biosciences가 Feb 24, 2026에 분기 실적을 발표했습니다:
